Streetbeat News

Earnings

SYRE

Spyre Therapeutics, Inc. (NASDAQ:SYRE), a biotech company focusing on Inflammatory Bowel Disease (IBD) treatments, announced that three abstracts regarding its lead product candidates, SPY001 and SPY002, will be presented at the 19th Annual Congress of the European Crohn's and Colitis Organization (ECCO) in Stockholm, Sweden. These presentations will highlight preclinical findings and the potential for extended dosing intervals. Phase 1 clinical studies for both candidates are expected to begin this year.

Portfolio Pulse from Benzinga Newsdesk

February 08, 2024 | 12:34 pm

LITE

Lumentum Holdings projects its Q3 2024 adjusted EPS to be between $0.20 and $0.35, compared to the estimated $0.32. The company also forecasts revenue to be in the range of $350M to $380M, against an estimated $379.179M.

Portfolio Pulse from Benzinga Newsdesk

February 08, 2024 | 12:33 pm

IMKTA

Ingles Markets (NASDAQ:IMKTA) reported a decrease in Q1 earnings per share to $2.28 from $3.65 YoY and a slight decrease in sales to $1.48B from $1.49B YoY.

Portfolio Pulse from Benzinga Newsdesk

February 08, 2024 | 12:33 pm

SPH

Suburban Propane Partners (NYSE:SPH) reported Q1 earnings of $0.38 per share, missing the consensus estimate of $0.63 by 39.68%, and a 46.48% decrease from last year's $0.71. Sales were $365.83M, slightly above the $365M estimate but 7.96% lower than the previous year's $397.47M.

Portfolio Pulse from Benzinga Newsdesk

February 08, 2024 | 12:33 pm

SWI

SolarWinds (NYSE:SWI) reported Q4 adjusted EPS of $0.24, surpassing the $0.21 estimate, and sales of $198.14M, exceeding the $190.43M estimate. This represents a 26.32% increase in earnings and a 5.92% increase in sales over the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 08, 2024 | 12:32 pm

ICE

Intercontinental Exchange (ICE) reported Q4 2023 adjusted EPS of $1.33, surpassing the $1.29 analyst estimate. Quarterly sales reached $2.20B, meeting expectations and marking a 24.43% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

February 08, 2024 | 12:31 pm

LITE

Lumentum Holdings (NASDAQ:LITE) reported Q2 2024 adjusted EPS of $0.32, surpassing the $0.30 estimate, with sales of $366.80M also beating the $363.32M estimate. However, this represents a 27.51% decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 08, 2024 | 12:31 pm

KVUE

Kenvue shares are trading lower following mixed Q4 results and a warning about potential challenges due to the macroeconomic environment.

Portfolio Pulse from Benzinga Newsdesk

February 08, 2024 | 12:23 pm

TDG

TransDigm has updated its FY24 outlook, raising its sales forecast to $7.58B-$7.76B from the previous $7.48B-$7.68B, against a $7.63B estimate. However, it has revised its adjusted EPS forecast down to $29.97-$31.73 from the earlier $31.00-$32.94, compared to a $32.31 estimate.

Portfolio Pulse from Benzinga Newsdesk

February 08, 2024 | 12:20 pm

BAX

Baxter International Inc. has provided its financial forecast for FY24, projecting an adjusted EPS of $2.85-$2.95, which is in line with the consensus estimate of $2.94. The company also expects sales growth of about 2% for the year, both on a reported and constant currency basis.

Portfolio Pulse from Benzinga Newsdesk

February 08, 2024 | 12:20 pm